Royalty Pharma Ups Hostile Bid To $6.3B As Elan Maneuvers
Elan Corp. PLC unveiled a slew of transactions on Monday designed to outflank hostile bidder Royalty Pharma Inc., but Royalty simply sweetened its offer to $6.3 billion and ripped Elan's management...To view the full article, register now.
Already a subscriber? Click here to view full article